It is plausible that the increased insulin-staining area reflects the release of insulin to control hyperglycemia in the setting of obesity and insulin resistance (Fig. 1B and Table 1), as this group was the only one to exhibit good glycemic control at later time points (18–20 weeks). The gene discussed is INS; the disease is Hyperglycemia.